The laser lithotripsy devices market has seen considerable growth due to a variety of factors.
• In recent times, the market size for laser lithotripsy devices has seen rapid expansion. It is anticipated to rise from a worth of $2.15 billion in 2024 to $2.4 billion in 2025, growing at an impressive compound annual growth rate (CAGR) of 11.3%.
The growth in past periods is due to factors such as the rising occurrence of urolithiasis, increased healthcare spending, a growing preference for non-invasive procedures, a rising number of specialty clinics and hospitals focusing on urology, and an increase in surgical procedures.
The laser lithotripsy devices market is expected to maintain its strong growth trajectory in upcoming years.
• Expectations are high for the laser lithotripsy devices market to experience a significant expansion in the upcoming years. The market is projected to escalate to $3.64 billion by 2029, with a compound annual growth rate (CAGR) of 11.0%.
The projected escalation for the forecast period is due to the growing incidence of kidney stones, increasing need for outpatient procedures, elevated preference for sophisticated imaging procedures, increasing incidences of metabolic diseases, and an increased demand for better patient results. Key trends anticipated during this forecast timeline include the adoption of less invasive techniques, the creation of portable laser tools, advancements in laser wavelengths, incorporation of robotic systems, and invention of multi-functional devices.
The surge in cases of kidney diseases is anticipated to stimulate the rise of the laser lithotripsy device market. The escalation in kidney disorders is predominantly the result of increasing prevalences of diabetes and hypertension, conditions which impair the kidneys' performance. Furthermore, lifestyle aspects such as obesity and physical inactivity add significantly to this growing trend. Laser lithotripsy devices are leveraged to break down kidney stones into tinier bits, allowing them to be passed or removed with less invasive procedures. For example, in June 2023, Kidney Research UK, a charitable organization in the UK, approximated that 7.19 million individuals in the UK were suffering from chronic kidney disease in 2023, accounting for over 10% of the UK's population and forecasted to rise to 7.61 million people by 2033. Consequently, the surge in kidney disease cases is propelling the growth of the laser lithotripsy device market.
The laser lithotripsy devices market covered in this report is segmented –
1) By Type: Holmium Yttrium Aluminum Garnet (YAG) Laser Lithotripsy, Thulium Fiber Laser Lithotripsy, Other Types
2) By Power Type: Low-Power, Mid-Power, High-Power
3) By Distribution Channel: Direct Sales, Distributors
4) By Application: Hospitals, Clinics, Ambulatory Surgical Centers, Research Institutes
5) By End-User: Public, Private
Subsegments:
1) By Holmium Yttrium Aluminum Garnet (YAG) Laser Lithotripsy: Portable Holmium YAG Laser Lithotripsy Devices, High-Power Holmium YAG Laser Lithotripsy Devices, Holmium YAG Laser Lithotripsy Systems for Urological Procedures
2) By Thulium Fiber Laser Lithotripsy: High-Energy Thulium Fiber Laser Lithotripsy Devices, Thulium Fiber Laser Lithotripsy Systems for Kidney Stones, Thulium Fiber Laser Lithotripsy Systems for Urinary Tract Stones
3) By Other Types: Diode Laser Lithotripsy, Dye Laser Lithotripsy, Carbon Dioxide (CO2) Laser Lithotripsy, Erbium Laser Lithotripsy
Significant players in the laser lithotripsy devices market are pioneering the creation of more accurate and effective lasers, such as holmium laser technology. This technology aims to improve patient results and operational efficiency in urology procedures. Holmium laser technology employs a holmium laser with a wavelength strongly absorbed by water and soft tissues, making it perfect for lithotripsy procedures to fragment kidney stones. For example, in November 2022, Apollo Hospitals, a healthcare firm based in India, introduced Moses 2.0, the country's first advanced laser technology designed to treat large kidney stones and prostate hypertrophy. This endoscopic procedure doesn't require any cuts, reducing pain and bleeding, which is particularly beneficial for those on anticoagulants. A high-power Holmium laser (120 watts) that auto-adjusts to diminish blood clotting and bleeding is used in the process, resulting in surgery times of approximately one hour. The procedure enhances the success rate of kidney stone fragmentation and prostate size reduction. The Moses laser technology fragmentation (MLTF) is an effective treatment for stones of any size, with verified results.
Major companies operating in the laser lithotripsy devices market are:
• Becton
• Dickinson and Company (BD)
• Boston Scientific Corporation
• Olympus Corporation
• Cook Medical Incorporated
• Karl Storz SE & Co. KG
• IPG Photonics Corporation
• Richard Wolf GmbH
• Dornier MedTech GmbH
• EDAP TMS S.A.
• EMS Electro Medical Systems SA
• Quanta System S.p.A.
• OmniGuide Holdings Inc.
• Biolitec AG
• Allengers Medical Systems Ltd.
• Rocamed SAM
• Jena Surgical GmbH
• Hyper Photonics s.r.l.
• Trimedyne Inc.
• Convergent Laser Technologies
• Potent Medical Inc.
• Surgical Lasers Inc.
North America was the largest region in the laser lithotripsy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the laser lithotripsy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.